Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constance Thibault

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Bulletin Du Cancer|January 1, 2019
Constance Thibault
Hematology/Oncology Clinics of North America|May 7, 2021
Emerging Targeted Therapy for Bladder CancerConstance Thibault, Yohann Loriot
Bulletin Du Cancer|April 9, 2023
[New drugs approval: Darolutamide - triplet therapy for hormone-sensitive metastastic prostate cancer]Lucie Houdou, Constance Thibault
European Urology Focus|October 9, 2024
Charting New Territories in Metastatic Prostate Cancer: A Convergence of Innovation and HopeConstance Thibault, Stéphane Oudard
Bulletin Du Cancer|May 30, 2015
[New therapies in metastatic castration resistant prostate cancer]Constance Thibault, Christophe Massard
Bulletin Du Cancer|July 5, 2020
[Innovations in systemic treatment of urothelial carcinoma]Constance Thibault, Marine Gross-Goupil
European Urology|December 9, 2019
Studying Rarity in Bladder CancerConstance Thibault, Pernelle Lavaud, Yohann Loriot
European Heart Journal|August 15, 2018
Immune checkpoint inhibitors myocarditis: not all cases are clinically patentConstance Thibault, Yann Vano, Gilles Soulat, et al.
Bulletin Du Cancer|January 1, 2019
Yann-Alexandre Vano, Audrey Simonaggio, Constance Thibault, et al.
Oncoimmunology|March 4, 2021
Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancerElise F Nassif, Constance Thibault, Stéphane Oudard, et al.
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Bulletin Du Cancer|January 1, 2019
Constance Thibault
Hematology/Oncology Clinics of North America|May 7, 2021
Emerging Targeted Therapy for Bladder CancerConstance Thibault, Yohann Loriot
Bulletin Du Cancer|April 9, 2023
[New drugs approval: Darolutamide - triplet therapy for hormone-sensitive metastastic prostate cancer]Lucie Houdou, Constance Thibault
European Urology Focus|October 9, 2024
Charting New Territories in Metastatic Prostate Cancer: A Convergence of Innovation and HopeConstance Thibault, Stéphane Oudard
Bulletin Du Cancer|May 30, 2015
[New therapies in metastatic castration resistant prostate cancer]Constance Thibault, Christophe Massard
Bulletin Du Cancer|July 5, 2020
[Innovations in systemic treatment of urothelial carcinoma]Constance Thibault, Marine Gross-Goupil
European Urology|December 9, 2019
Studying Rarity in Bladder CancerConstance Thibault, Pernelle Lavaud, Yohann Loriot
European Heart Journal|August 15, 2018
Immune checkpoint inhibitors myocarditis: not all cases are clinically patentConstance Thibault, Yann Vano, Gilles Soulat, et al.
Bulletin Du Cancer|January 1, 2019
Yann-Alexandre Vano, Audrey Simonaggio, Constance Thibault, et al.
Oncoimmunology|March 4, 2021
Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancerElise F Nassif, Constance Thibault, Stéphane Oudard, et al.
Pageof 11